class name | count |
---|
class name | count |
---|---|
Aspergillaceae | 4 |
Elaphomycetaceae | 3 |
Nocardiaceae | 1 |
br08003 Category | # of metabolite |
---|
br08003 Category | KEGG ID | KNApSAcK ID |
---|
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
figure |
---|---|---|---|---|---|---|
C00000547
![]() |
Lovastatin
/ Monacolin K / (+)-Mevinolin |
CHEMBL503
CHEMBL79583 CHEMBL333443 CHEMBL140273 CHEMBL167159 CHEMBL1230589 CHEMBL1394089 CHEMBL1515625 |
D008148
|
125 / 74 / 58 | 75 / 61 |
![]() |
C00000564
![]() |
Mevastatin
/ Antibiotic ML 236B / Compactin(Penicillium) |
CHEMBL300596
CHEMBL54440 CHEMBL1330357 CHEMBL1355448 CHEMBL1526351 CHEMBL1710493 CHEMBL2115055 CHEMBL2115058 CHEMBL2115471 CHEMBL2115472 |
115 / 82 / 83 |
![]() |
||
C00017080
![]() |
L 669262
|
C068819
|
![]() |
|||
C00017831
![]() |
Monacolin M
|
C051483
|
![]() |
|||
C00018332
![]() |
Dihydromevinolin
|
CHEMBL54712
CHEMBL76114 |
C031351
|
![]() |
||
C00018337
![]() |
Dihydrocompactin
/ (+)-Dihydrocompactin / 4a,5-Dihydrocompactin |
C031380
|
![]() |
|||
C00018631
![]() |
Monacolin X
|
C045374
|
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000547 C00000564 | 1 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00000547 C00000564 | 1 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000547 C00000564 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000547 C00000564 | 4 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000547 C00000564 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000547 C00000564 | 0 / 1 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000547 C00000564 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000547 C00000564 | 0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000547 C00000564 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00000547 C00000564 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000547 C00000564 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000547 C00000564 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000547 C00000564 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000547 C00000564 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000547 C00000564 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000547 C00000564 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000547 C00000564 | 1 / 1 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000547 C00000564 | 2 / 2 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000547 C00000564 | 11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000547 C00000564 | 3 / 2 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000547 C00000564 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000547 C00000564 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000547 C00000564 | 1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000547 C00000564 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000547 C00000564 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000547 C00000564 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000547 C00000564 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000547 C00000564 | 1 / 1 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000547 C00000564 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000547 C00000564 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000547 C00000564 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000547 C00000564 | 0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000547 C00000564 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000547 C00000564 | 1 / 8 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000547 C00000564 | 2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000547 C00000564 | 2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000547 C00000564 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000547 C00000564 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000547 C00000564 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000547 C00000564 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000547 C00000564 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000547 C00000564 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000547 C00000564 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000547 C00000564 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000547 C00000564 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000547 C00000564 | 1 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000547 C00000564 | 0 / 1 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000547 C00000564 | 1 / 1 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000547 C00000564 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00000547 C00000564 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000547 C00000564 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000547 C00000564 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000547 C00000564 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000547 C00000564 | 2 / 0 |
O75496 | Geminin | Unclassified protein | C00000547 C00000564 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000547 C00000564 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000547 C00000564 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000547 C00000564 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000547 C00000564 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000547 C00000564 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000547 C00000564 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000547 C00000564 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000547 C00000564 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000547 C00000564 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000547 C00000564 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000547 C00000564 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000547 C00000564 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00000547 C00000564 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000547 C00000564 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00000547 C00000564 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000547 C00000564 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000547 C00000564 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000547 C00000564 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000547 C00000564 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00000547 C00000564 | 1 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000547 C00000564 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000547 C00000564 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000547 C00000564 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000547 C00000564 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000547 C00000564 | 1 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000547 C00000564 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000547 C00000564 | 2 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000547 C00000564 | 0 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000547 C00000564 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000547 C00000564 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000547 C00000564 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000547 C00000564 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000547 C00000564 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000547 C00000564 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000547 C00000564 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000547 C00000564 | 1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000547 C00000564 | 0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000547 C00000564 | 2 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00000547 C00000564 | 1 / 1 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00000547 | 1 / 1 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000564 | 5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000547 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00000564 | 0 / 0 |
Q8NER1 | Transient receptor potential cation channel subfamily V member 1 | TRPV (Vanilloid) | C00000564 | 0 / 0 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00000547 | 5 / 3 |
P14324 | Farnesyl pyrophosphate synthase | Transferase | C00000547 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00000547 | 1 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00000564 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000564 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00000564 | 7 / 3 |
P46721 | Solute carrier organic anion transporter family member 1A2 | Unclassified protein | C00000547 | 0 / 0 |
P17301 | Integrin alpha-2 | Unclassified protein | C00000547 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00000564 | 1 / 1 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00000547 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000564 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000547 | 0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | C00000547 | 4 / 1 |
Q92769 | Histone deacetylase 2 | Hydrolase | C00000547 | 0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000564 | 0 / 0 |
P20701 | Integrin alpha-L | Membrane receptor | C00000547 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000564 | 1 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000547 | 4 / 3 |
P54132 | Bloom syndrome protein | Enzyme | C00000564 | 1 / 2 |
P08183 | Multidrug resistance protein 1 | drug | C00000547 | 1 / 0 |
Q16850 | Lanosterol 14-alpha demethylase | Cytochrome P450 51A1 | C00000547 | 0 / 0 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | C00000547 | 0 / 0 |
Q13547 | Histone deacetylase 1 | Hydrolase | C00000547 | 0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | C00000547 | 0 / 0 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00000547 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00000547 | 1 / 0 |
P05362 | Intercellular adhesion molecule 1 | Adhesion | C00000547 | 1 / 2 |
Q9UBN7 | Histone deacetylase 6 | Hydrolase | C00000547 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000547 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00000564 | 7 / 37 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000547 | 1 / 1 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00000564 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000564 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000564 | 1 / 2 |
P05107 | Integrin beta-2 | Membrane receptor | C00000547 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00000547
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00000547
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00000547
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00000547
|
9465 | AKAP7, AKAP15, AKAP18 | A kinase (PRKA) anchor protein 7 |
C00000547
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000547
|
287 | ANK2, ANK-2, LQT4, brank-2 | ankyrin 2, neuronal |
C00000547
|
335 | APOA1 | apolipoprotein A-I |
C00000547
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00000547
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000547
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000547
|
10018 | BCL2L11, BAM, BIM, BOD | BCL2-like 11 (apoptosis facilitator) |
C00000547
|
332 | BIRC5, API4, EPR-1 | baculoviral IAP repeat containing 5 |
C00000547
|
835 | CASP2, CASP-2, ICH1, NEDD-2, NEDD2, PPP1R57 | caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) |
C00000547
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000547
|
839 | CASP6, MCH2 | caspase 6, apoptosis-related cysteine peptidase (EC:3.4.22.59) |
C00000547
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000547
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000547
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000547
|
896 | CCND3 | cyclin D3 |
C00000547
|
960 | CD44, CDW44, CSPG8, ECMR-III, HCELL, HUTCH-I, IN, LHR, MC56, MDU2, MDU3, MIC4, Pgp1 | CD44 molecule (Indian blood group) |
C00000547
|
998 | CDC42, CDC42Hs, G25K | cell division cycle 42 |
C00000547
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00000547
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00000547
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00000547
|
1063 | CENPF, CENF, PRO1779, hcp-1 | centromere protein F, 350/400kDa |
C00000547
|
1111 | CHEK1, CHK1 | checkpoint kinase 1 (EC:2.7.11.1) |
C00000547
|
1499 | CTNNB1, CTNNB, MRD19, armadillo | catenin (cadherin-associated protein), beta 1, 88kDa |
C00000547
|
1558 | CYP2C8, CPC8, CYPIIC8, MP-12/MP-20 | cytochrome P450, family 2, subfamily C, polypeptide 8 (EC:1.14.14.1) |
C00000547
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00000547
|
55840 | EAF2, BM040, TRAITS, U19 | ELL associated factor 2 |
C00000547
|
1950 | EGF, HOMG4, URG | epidermal growth factor |
C00000547
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00000547
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000547
|
356 | FASLG, ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L, FASL, TNFSF6 | Fas ligand (TNF superfamily, member 6) |
C00000547
|
2194 | FASN, FAS, OA-519, SDR27X1 | fatty acid synthase (EC:2.3.1.85 2.3.1.38 2.3.1.39 2.3.1.41 3.1.2.14 4.2.1.59 1.1.1.100 1.3.1.39) |
C00000547
|
2222 | FDFT1, DGPT, ERG9, SQS, SS | farnesyl-diphosphate farnesyltransferase 1 (EC:2.5.1.21) |
C00000547
|
2596 | GAP43, B-50, PP46 | growth associated protein 43 |
C00000547
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000547
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00000547
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00000547
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000547
|
3265 | HRAS, C-BAS/HAS, C-H-RAS, C-HA-RAS1, CTLO, H-RASIDX, HAMSV, HRAS1, K-RAS, N-RAS, RASH1 | Harvey rat sarcoma viral oncogene homolog |
C00000547
|
3638 | INSIG1, CL-6, CL6 | insulin induced gene 1 |
C00000547
|
3845 | KRAS, C-K-RAS, CFC2, K-RAS2A, K-RAS2B, K-RAS4A, K-RAS4B, KI-RAS, KRAS1, KRAS2, NS, NS3, RASK2 | Kirsten rat sarcoma viral oncogene homolog |
C00000547
|
3949 | LDLR, FH, FHC, LDLCQ2 | low density lipoprotein receptor |
C00000547
|
51176 | LEF1, LEF-1, TCF10, TCF1ALPHA, TCF7L3 | lymphoid enhancer-binding factor 1 |
C00000547
|
4001 | LMNB1, ADLD, LMN, LMN2, LMNB | lamin B1 |
C00000547
|
4018 | LPA, AK38, APOA, LP | lipoprotein, Lp(a) (EC:3.4.21.-) |
C00000547
|
9663 | LPIN2 | lipin 2 (EC:3.1.3.4) |
C00000547
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000547
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000547
|
4313 | MMP2, CLG4, CLG4A, MMP-II, MONA, TBE-1 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) |
C00000547
|
4318 | MMP9, CLG4B, GELB, MANDP2, MMP-9 | matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) |
C00000547
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00000547
|
4893 | NRAS, ALPS4, N-ras, NRAS1, NS6 | neuroblastoma RAS viral (v-ras) oncogene homolog |
C00000547
|
29780 | PARVB, CGI-56 | parvin, beta |
C00000547
|
5446 | PON3 | paraoxonase 3 (EC:3.1.1.2 3.1.8.1 3.1.1.81) |
C00000547
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000547
|
5728 | PTEN, 10q23del, BZS, CWS1, DEC, GLM2, MHAM, MMAC1, PTEN1, TEP1 | phosphatase and tensin homolog (EC:3.1.3.67 3.1.3.16 3.1.3.48) |
C00000547
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000547
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00000547
|
5894 | RAF1, CRAF, NS5, Raf-1, c-Raf | v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) |
C00000547
|
5906 | RAP1A, KREV-1, KREV1, RAP1, SMGP21 | RAP1A, member of RAS oncogene family |
C00000547
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00000547
|
387 | RHOA, ARH12, ARHA, RHO12, RHOH12 | ras homolog family member A |
C00000547
|
388 | RHOB, ARH6, ARHB, MST081, MSTP081, RHOH6 | ras homolog family member B |
C00000547
|
10599 | SLCO1B1, HBLRR, LST-1, LST1, OATP-C, OATP1B1, OATP2, OATPC, SLC21A6 | solute carrier organic anion transporter family, member 1B1 |
C00000547
|
6721 | SREBF2, SREBP-2, SREBP2, bHLHd2 | sterol regulatory element binding transcription factor 2 |
C00000547
|
261729 | STEAP2, IPCA1, PCANAP1, PUMPCn, STAMP1, STMP | STEAP family member 2, metalloreductase |
C00000547
|
7038 | TG, AITD3, TGN | thyroglobulin |
C00000547
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00000547
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00000547
|
8743 | TNFSF10, APO2L, Apo-2L, CD253, TL2, TRAIL | tumor necrosis factor (ligand) superfamily, member 10 |
C00000547
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000547
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P31749
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P31749
P84022 |
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 P37231 |
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#116920 | Leukocyte adhesion deficiency, type i; lad |
P05107
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#611162 | Malaria, susceptibility to |
P05362
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
P37231 |
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#176920 | Proteus syndrome |
P31749
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00099 | Leukocyte adhesion deficiency (LAD) |
P05107
(related)
|
H00083 | Allograft rejection |
P05362
(related)
|
H00080 | Systemic lupus erythematosus |
P05362
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D058186 | Acute Kidney Injury |
C00000547
|
D000743 | Anemia, Hemolytic |
C00000547
|
D000799 | Angioedema |
C00000547
|
D000855 | Anorexia |
C00000547
|
D018771 | Arthralgia |
C00000547
|
D001930 | Brain Injuries |
C00000547
|
D002493 | Central Nervous System Diseases |
C00000547
|
D002779 | Cholestasis |
C00000547
|
D002780 | Cholestasis, Intrahepatic |
C00000547
|
D003110 | Colonic Neoplasms |
C00000547
|
D003324 | Coronary Artery Disease |
C00000547
|
D003866 | Depressive Disorder |
C00000547
|
D003882 | Dermatomyositis |
C00000547
|
D056486 | Drug-Induced Liver Injury |
C00000547
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00000547
|
D004401 | Dysarthria |
C00000547
|
D050171 | Dyslipidemias |
C00000547
|
D001068 | Eating Disorders |
C00000547
|
D005076 | Exanthema |
C00000547
|
D005483 | Flushing |
C00000547
|
D005767 | Gastrointestinal Diseases |
C00000547
|
D006261 | Headache |
C00000547
|
D006330 | Heart Defects, Congenital |
C00000547
|
D006937 | Hypercholesterolemia |
C00000547
|
D006949 | Hyperlipidemias |
C00000547
|
D006938 | Hyperlipoproteinemia Type II |
C00000547
|
D006973 | Hypertension |
C00000547
|
D015228 | Hypertriglyceridemia |
C00000547
|
D006987 | Hypesthesia |
C00000547
|
D052456 | Hypoalphalipoproteinemias |
C00000547
|
D007565 | Jaundice |
C00000547
|
D041781 | Jaundice, Obstructive |
C00000547
|
D007676 | Kidney Failure, Chronic |
C00000547
|
D008103 | Liver Cirrhosis |
C00000547
|
D008223 | Lymphoma |
C00000547
|
D008325 | Mammary Neoplasms, Experimental |
C00000547
|
D017240 | Mitochondrial Myopathies |
C00000547
|
D019964 | Mood Disorders |
C00000547
|
D009069 | Movement Disorders |
C00000547
|
D009120 | Muscle Cramp |
C00000547
|
D018908 | Muscle Weakness |
C00000547
|
D009135 | Muscular Diseases |
C00000547
|
D009212 | Myoglobinuria |
C00000547
|
D009220 | Myositis |
C00000547
|
D009336 | Necrosis |
C00000547
|
D000857 | Olfaction Disorders |
C00000547
|
D009846 | Oliguria |
C00000547
|
D010146 | Pain |
C00000547
|
D010190 | Pancreatic Neoplasms |
C00000547
|
D010292 | Paresthesia |
C00000547
|
D010523 | Peripheral Nervous System Diseases |
C00000547
|
D011115 | Polyneuropathies |
C00000547
|
D011507 | Proteinuria |
C00000547
|
D051437 | Renal Insufficiency |
C00000547
|
D012206 | Rhabdomyolysis |
C00000547
|
D012509 | Sarcoma |
C00000547
|
D012817 | Signs and Symptoms, Digestive |
C00000547
|
D012893 | Sleep Disorders |
C00000547
|
D007319 | Sleep Initiation and Maintenance Disorders |
C00000547
|
D013733 | Testicular Diseases |
C00000547
|
D014581 | Urticaria |
C00000547
|